Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: The study aimed to investigate the effectiveness and tolerance of biological disease-modifying antirheumatic drugs (bDMARDs) therapy administered concomitantly with tacrolimus (TAC) treatment in patients with rheumatoid arthritis.
Methods: 2792 patients who underwent therapy with five bDMARDs (etanercept: ETN, adalimumab, golimumab, tocilizumab, and abatacept: ABT) were enrolled. Among the study subjects, 1582 were concomitant methotrexate (MTX group), 147 were concomitant TAC (TAC group), and 1063 were non-concomitant MTX and TAC (non-MTX/TAC group). The primary outcome was the incident rate of discontinuation of bDMARDs by adverse events (AEs) or loss of efficacy.
Results: Concerning the analysis for each reasons of discontinuation, including AEs and loss of efficacy, the hazards ratio (HR) was significantly lower in the TAC group than in non-MTX/TAC groups (AEs: HR = 0.39, 95% confidence interval, 0.23-0.68, loss of efficacy: HR = 0.49, 95% confidence interval, 0.30-0.78). The loss of efficacy with the use of ETN and ABT was lower in the TAC group than in non-MTX/TAC groups. Concomitant TAC did not induce elevated risk for discontinuation of AEs in all bDMARD analyses.
Conclusions: Concomitant TAC with ABT or ETN showed higher retention rates than bDMARDs therapy without TAC or MTX. AEs did not increase over long-term observation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/mr/roac025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pericardial adipose tissue promotes transition to heart failure with reduced ejection fraction upon pressure-overload in mice.
Basic Res Cardiol
July 2025
Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
In patients, severity of pressure-induced heart failure (HF) due to aortic stenosis and metabolic disorder correlates with thickness and mass of epicardial adipose tissue (EAT). We examined the role of the less studied pericardial adipose tissue (PAT) during manifestation and progression of pressure-induced HF in mice. Progressive remodeling was assessed in C57BL/6 J males, aged 9 weeks, following sham surgery or transverse aortic constriction (TAC) for 1 week (early pressure-overload), 8 (chronic pressure-overload), or 12 weeks (HF with reduced ejection fraction, HFrEF) with or without concomitant PAT excision.
View Article and Find Full Text PDFPermissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft.
Sci Rep
July 2025
Latner Thoracic Research Laboratories, Toronto General Hospital Research Institute, Toronto, Canada.
In lung transplantation (LT), alloreactive T cell priming begins in the graft, a process that can be inhibited by seeding the graft with recipient-derived expanded polyclonal regulatory T cells (Tregs) using ex vivo lung perfusion (EVLP) prior to transplantation. However, this therapy alone cannot attenuate acute rejection in non-immunosuppressed animals. Interleukin 2 (IL-2)-anti-IL-2 antibody complexes (IL-2 C) promote Treg expansion in vivo with concomitant tacrolimus (Tac) administration.
View Article and Find Full Text PDFTrim38 attenuates pressure overload‑induced cardiac hypertrophy by suppressing the TAK1/JNK/P38 signaling pathway.
Int J Mol Med
June 2025
Institute of Cardiovascular Diseases, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China.
Pathological cardiac hypertrophy is a major contributor to heart failure (HF), resulting in high mortality rates worldwide; therefore, identifying key molecules in pathological cardiac hypertrophy is of critical importance for preventing or reversing HF. Tripartite motif 38 (Trim38) is an E3 ubiquitin ligase that serves a pivotal role in various diseases. The present study aimed to elucidate the regulatory role of Trim38 in pressure overload‑induced pathological cardiac hypertrophy and to explore its underlying molecular mechanisms.
View Article and Find Full Text PDFEnhancing the Quality of Indoor-Grown Basil Microgreens with Low-Dose UV-B or UV-C Light Supplementation.
Int J Mol Sci
March 2025
Department of Environmental Biology, Jan Kochanowski University of Kielce, Uniwersytecka 7, 25-406 Kielce, Poland.
Controlled-environment crop production often weakens plants' defense mechanisms, reducing the accumulation of protective phytochemicals essential to human health. Our previous studies demonstrated that short-term supplementation of low-dose ultraviolet (UV) light to the red-green-blue (RGB) spectrum effectively boosts secondary metabolite (SM) synthesis and antioxidant capacity in lettuce. This study explored whether similar effects occur in basil cultivars by supplementing the RGB spectrum with ultraviolet B (UV-B, 311 nm) or ultraviolet C (UV-C, 254 nm) light shortly before harvest.
View Article and Find Full Text PDFDevelopment and validation of a nomogram to predict linezolid-induced thrombocytopenia in hospitalized adults.
BMC Pharmacol Toxicol
February 2025
Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Department of Pharmacy, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, No. 20 Jinyu Avenue, Liangjiang New District
Background: Linezolid (LZD) is used to treat infectious diseases caused by Gram-positive bacteria, but thrombocytopenia is one of the main adverse reactions to LZD administration. Early prediction of linezolid-induced thrombocytopenia (LI-TP) is of great importance to improve the clinical outcomes and prognoses. The aim of this study was to develop and validate a prediction model for LI-TP.
View Article and Find Full Text PDF